by LaurenEBS | May 6, 2026 | Upcoming Events
You are warmly invited to join our National Virtual Fundraising Campaign, a dedicated event focused on hope, progress, and the future of multiple myeloma care.This gathering unites our national community to raise essential funds for your local research team’s...
by LaurenEBS | Feb 27, 2026 | Featured Events, Upcoming Events
We are delighted to officially invite our patients, researchers, healthcare professionals, and dedicated supporters to join us for an evening of elegance, entertainment, and profound purpose. The Trial to Triumph Gala brings our community together under one roof to...
by LaurenEBS | Feb 27, 2026 | Featured News, Latest News
Individuals in Canada who are currently receiving or have previously received belantamab mafodotin for multiple myeloma (MM) may be eligible to participate in a research interview study. This study aims to better understand patients’ experiences with belantamab...
by LaurenEBS | Nov 1, 2025 | Featured News, Latest News
We are pleased to share that the study Real-World Outcomes in Myeloma Patients With t(11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical Database has been published in Clinical Lymphoma Myeloma & Leukemia. Congratulations to...
by LaurenEBS | Sep 1, 2025 | Featured News, Latest News
We are delighted to announce that a poster on Tumor-reactive γδ T Cells Mediate Responses to the Antibody Drug Conjugate Belantamab Mafodotin in Multiple Myeloma was presented at the International Myeloma Society (IMS) meeting and subsequently published in Clinical...
